321
Participants
Start Date
March 31, 2014
Primary Completion Date
February 29, 2016
Study Completion Date
December 31, 2016
Ruxolitinib
5 mg tablets to be administered by mouth twice daily (BID)
Placebo
5 mg tablets to be administered by mouth twice daily (BID)
Capecitabine
150 and 500 mg tablets to be administered by mouth twice daily (BID)
Avondale
Chandler
Gilbert
Glendale
Mesa
Phoenix
Scottsdale
Surprise
Tucson
Hot Springs
Jonesboro
Anaheim
Bakersfield
Berkeley
Beverly Hills
Chula Vista
Covina
Downey
El Cajon
Fullerton
Gilroy
Glendale
La Mesa
Long Beach
Los Angeles
Lynwood
Modesto
Montebello
Northridge
Oceanside
Orange
Redondo Beach
San Diego
San Francisco
San Luis Obispo
Santa Ana
Santa Maria
Santa Monica
Torrance
Whittier
Aurora
Boulder
Colorado Springs
Denver
Grand Junction
Longmont
Thornton
New Britain
New Haven
Southington
Trumbull
Newark
Boca Raton
Hollywood
Miami
Pembroke Pines
Atlanta
Austell
Carrollton
Cartersville
Douglasville
Marietta
Newnan
Rome
Thomasville
Arlington Heights
Chicago
Hinsdale
Niles
Urbana
Goshen
Indianapolis
Topeka
Ashland
Louisville
Metairie
New Orleans
Scarborough
Annapolis
Baltimore
Bethesda
Rockville
Worcester
Ann Arbor
Detroit
Kalamazoo
Lansing
Woodbury
Bolivar
Kansas City
St Louis
Kalispell
Hastings
Omaha
Papillion
Las Vegas
Lebanon
East Orange
Farmington
Binghamton
Fresh Meadows
Hudson
Johnson City
New York
Nyack
Rochester
The Bronx
Durham
Wake Forest
Winston-Salem
Canton
Columbus
Middletown
Oregon
Toledo
Eugene
Portland
Springfield
Tualatin
Philadelphia
Charleston
Seneca
Spartanburg
Chattanooga
Knoxville
Memphis
Nashville
Arlington
Austin
Beaumont
Bedford
Cedar Park
Dallas
Denton
El Paso
Fort Worth
Houston
Plano
Round Rock
San Antonio
Temple
Tyler
Waco
Ogden
Salt Lake City
Blacksburg
Richmond
Roanoke
Salem
Wytheville
Seattle
Vancouver
Madison
Australian Capital Territory
New South Wales
South Australia
Victoria
Aalst
Bruges
Brussels
Edegem
Ghent
Gilly
Kortrijk
Leuven
Calgary
Oshawa
Sault Ste. Marie
Toronto
Greenfield Park
Laval
Montreal
Aschaffenburg
Berlin
Bochum
Cologne
Essen
Frankford
Velbert
Aviano
Bari
Bergamo
Brescia
Cremona
Florence
Genova
Lido di Camaiore
Milan
Napoli
Pisa
Rimini
Roma
Auckland
Christchurch
Hamilton
Hwasun-gun
Seongnam-si
Seoul
Badajoz
Barcelona
Madrid
Málaga
Seville
Taichung
Tainan City
Taipei
Patumwan
Ratchathewi
Seetatarom
Aberdeen
Bangor
Birmingham
Boston
Bristol
Cardiff
Glasgow
Guildford
Harlow
Huddersfield
Lancaster
Leeds
London
Manchester
Metropolitan Borough of Wirral
Newcastle upon Tyne
Nottingham
Plymouth
Southampton
Sutton
Welwyn Garden City
Lead Sponsor
Incyte Corporation
INDUSTRY